tirzepatide shortage fda says is over after taking a second look FDA sets tirzepatide compounding deadlines

Yes, sulfur burps alone are not a reason to stop Mounjaro

As with all GLP-1 therapies, there are important safety considerations: Not suitable for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) May cause nausea, vomiting, diarrhea , especially during dose titration Monitor for signs of pancreatitis , gallbladder issues, or allergic reactions Not indicated for patients with Type 1 diabetes or those with severe gastrointestinal disorders Regular follow-ups, lab monitoring, and dose adjustments are part of the DrWell Methodology to ensure safe, effective outcomes

You can keep a weight loss journal , chronicling regular weigh-ins, measurements, dietary changes, and even daily steps

What if I need a higher dose

Scroll to ISI What is Wegovy